- The post-Lehman market peaked in Q2 2011 and Q2 2012 only to slow in Q3 each year due to concerns over the EU sovereign debt crisis and extreme market volatility.
- As a result of the market turmoil in the summer of 2011, many IPOs were put on hold and pushed into 2012, setting the stage for a strong start in 2012.
- 2012 was regarded by many as a strong year for technology and life sciences IPOs. Even so, there were fewer deals in 2012 than in 2007 and a fraction of the number in 1998.
- Many factors contribute to the smaller number of offerings in recent years, including the increased cost of going public in light of SOX and other enhanced regulatory requirements, fewer underwriters of sub $50M IPOs that were much more prevalent in the 1990's IPO market and the decimalization of the stock market.
- Forward looking, the question has become - Is there a strong pipeline heading into Q2 2013 similar to the lead into 2012?
Fenwick Releases Inaugural Technology And Life Sciences IPO Survey
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.